Evidence map›Paper›PMID 27488447›Full record

GuidelineZeitschrift fur Rheumatologie2016

[Treat-to-target (T2T) recommendation for patients with spondyloarthritis - translation into German].

U Kiltz, J Sieper, M Backhaus, B Buss, E Gromnica-Ihle, H Haíbel, L Hammel, K Karberg, S Rehart, M Rudwaleit and 3 more

Abstract readPractice Guideline
PubMed Publisher
In one paragraph

Guideline in Zeitschrift fur Rheumatologie, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

U KiltzRheumazentrum Ruhrgebiet, Claudiusstr. 45, 44649, Herne, Deutschland. uta.kiltz@elisabethgruppe.de.
J SieperCampus Benjamin Franklin, Charité Berlin, Hindenburgdamm 30, 12203, Berlin, Deutschland.
M BackhausPark-Klinik Weissensee, Berlin, Deutschland.
B BussCampus Benjamin Franklin, Charité Berlin, Hindenburgdamm 30, 12203, Berlin, Deutschland.
E Gromnica-IhleDeutsche Rheuma-Liga, Maximilianstr. 14, 53111, Bonn, Deutschland.
H HaíbelCampus Benjamin Franklin, Charité Berlin, Hindenburgdamm 30, 12203, Berlin, Deutschland.
L HammelDeutsche Vereinigung Morbus Bechterew e. V., Metzgergasse 16, 97421, Schweinfurt, Deutschland.
K KarbergPraxis für Rheumatologie und Innere Medizin, Schlosstrasse 110, Berlin, Deutschland.
S RehartAgaplesion Markus Krankenhaus, Klinik für Orthopädie und Unfallchirurgie, Wilhelm-Epstein Str. 4, Frankfurt, Deutschland.
M RudwaleitKlinikum Bielefeld Rosenhöhe, Bielefeld, Deutschland.
F SchuchRheumatologische Schwerpunktpraxis Erlangen, Möhrendorfer Str. 1c, Erlangen, Deutschland.
P Steffens-KorbankaRheumapraxis an der Hase, Osnabrück, Deutschland.
J BraunRheumazentrum Ruhrgebiet, Claudiusstr. 45, 44649, Herne, Deutschland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The management of patients with spondyloarthritis (SpA) has experienced a paradigm shift in recent years. This is true for the treatment of axial as well as peripheral manifestations. International treat to target (T2T) recommendations for SpA based on the T2T strategy have now also been published, which contain 5 higher level principles (A-E) in addition to the 15 recommendations. In order to make the recommendations known and to promote national distribution, German experts have now issued a translation of the T2T recommendations for SpA into German.

Indexed as

Clinical Decision-MakingEvidence-Based MedicineGermanyHumansOutcome Assessment, Health CarePatient Care PlanningPatient-Centered CareRheumatologySpondylarthritisTranslatingTreatment OutcomeDiseasePsoriatic arthritisRecommendationsSpondyloarthritisTreat-to-target

Identifiers

PMID27488447

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.